| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8924165 | JMV-Journal de Médecine Vasculaire | 2018 | 8 Pages |
Abstract
In 2008, we decided to enter the era of direct oral anticoagulants (DOACS). Was that the right decision to make? The answer will depend on how well we meet the conditions of proper use. This means avoiding underdosing and overdosing as well as understanding how DOACS were validated so that our prescriptions fulfill their role in the management of thrombotic disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
J.P. Laroche, F. Becker, J.F. Schved,